CTEV Claritev Corporation

Subscribe to $CTEV

Claritev Corporation

Subscribe to $CTEV

$CTEV

Business Services

Consumer Discretionary

IPO Year: 2020

Exchange: NYSE

Recent Analyst Ratings for Claritev Corporation

Date	Price Target	Rating	Analyst

See more ratings

Claritev Corporation Press Releases

Fastest customizable press release news feed in the world

Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy
Jigar S. Patel, MD, Named Chief Medical Officer Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership team to support the company's strategic growth, transformation and mission to bring transparency to the healthcare ecosystem with innovative products and solutions. Jigar S. Patel, MD, has been appointed Chief Medical Officer effective April 14, 2025. As a new member of the Executive Leadership Team, Patel will pro
4/17/25 12:06:00 PM ET
$CTEV
Business Services
Consumer Discretionary
Claritev's Ceres® Named "Data Solution of the Year for Insurance" in 2025 Data Breakthrough Awards Program
Prestigious International Awards Program Recognizes Outstanding Data Technology Products and Companies Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that one of its data and decision science solutions, Ceres®, has been selected as winner of the "Data Solution of the Year for Insurance" award in the 6th annual Data Breakthrough Awards' Industry Applications Category. Data Breakthrough, an independent market intelligence organization, recognizes the top companies, technologies and products in the global data technol
4/14/25 4:45:00 PM ET
$CTEV
Business Services
Consumer Discretionary
Claritev Corporation Announces First Quarter 2025 Earnings Conference Call
Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/events/login?show=fda0
4/10/25 8:30:00 AM ET
$CTEV
Business Services
Consumer Discretionary
ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks
Latest agreement expands access to the PHCS and MultiPlan Networks ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE:CTEV), previously MultiPlan, Inc. (NYSE:MPLN), a technology and data insights company focused on making healthcare more affordable, transparent, and fair for all. As part of the agreement, ClearNote Health's Avantect® Pancreatic Cancer Test will now be available to health plan members accessing Claritev's national PHCS and MultiPlan Networks. While early detection has vastly improved survival rates for many types of cancer, pancreatic cancer is often diagnos
3/12/25 8:03:00 AM ET
$CTEV
$MPLN
Business Services
Consumer Discretionary

Claritev Corporation

Recent Analyst Ratings for Claritev Corporation

Claritev Corporation

Recent Analyst Ratings for Claritev Corporation

Claritev Corporation Financials

Live finance-specific insights

Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

Claritev Corporation Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Pres., CEO & Executive Chair Dalton Travis bought $100,823 worth of shares (5,252 units at $19.20), increasing direct ownership by 2% to 239,285 units (SEC Form 4)

EVP&CFO Garis Douglas Michael bought $175,891 worth of shares (8,919 units at $19.72) (SEC Form 4)

Claritev Corporation Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SVP, General Counsel O'Neil Tara covered exercise/tax liability with 48 shares, decreasing direct ownership by 0.20% to 23,963 units (SEC Form 4)

SVP, Chief Accounting Officer Kozel Gerald covered exercise/tax liability with 74 shares, decreasing direct ownership by 0.13% to 57,815 units (SEC Form 4)

Director White Dale A. covered exercise/tax liability with 754 shares, decreasing direct ownership by 0.21% to 361,732 units (SEC Form 4)

EVP, Chief Digital Officer Kim Michael covered exercise/tax liability with 63 shares, decreasing direct ownership by 0.07% to 95,929 units (SEC Form 4)

Pres., CEO & Executive Chair Dalton Travis bought $100,823 worth of shares (5,252 units at $19.20), increasing direct ownership by 2% to 239,285 units (SEC Form 4)

EVP&CFO Garis Douglas Michael bought $175,891 worth of shares (8,919 units at $19.72) (SEC Form 4)

SVP, General Counsel O'Neil Tara covered exercise/tax liability with 993 shares and was granted 13,935 shares, increasing direct ownership by 117% to 24,011 units (SEC Form 4)

EVP, Chief Digital Officer Kim Michael covered exercise/tax liability with 2,330 shares and was granted 26,507 shares, increasing direct ownership by 34% to 95,992 units (SEC Form 4)

SVP, Chief People Officer Carol Nutter covered exercise/tax liability with 1,728 shares and was granted 12,255 shares, increasing direct ownership by 57% to 28,864 units (SEC Form 4)

Pres., CEO & Executive Chair Dalton Travis covered exercise/tax liability with 18,282 shares and was granted 127,203 shares, increasing direct ownership by 87% to 234,033 units (SEC Form 4)

Claritev Corporation Press Releases

Fastest customizable press release news feed in the world

Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy

Claritev's Ceres® Named "Data Solution of the Year for Insurance" in 2025 Data Breakthrough Awards Program

Claritev Corporation Announces First Quarter 2025 Earnings Conference Call

ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

Claritev Corporation SEC Filings

SEC Form DEFA14A filed by Claritev Corporation

SEC Form DEF 14A filed by Claritev Corporation

Claritev Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits